RC48 Suppresses Tumor Growth and Reduces Tumor Burden in the A2058 and SK-MEL-28 cells

Поделиться
HTML-код
  • Опубликовано: 7 фев 2025
  • The content of this video is based on BMC's publication of Weisong et al., 2024 "Combined therapy of dabrafenib and an anti-HER2 antibody-drug conjugate for advanced BRAF-mutant melanoma".

Комментарии •